ACET — Adicet Bio Inc · rev $2.5M

Adicet Bio Inc (ACET) is a biotechnology company listed on NASDAQ.

Latest reported ACET revenue for 2026-06-30 was $2.5M. Net income was -$41.6M. Revenue was up 87.0% from 2026-03-31 to 2026-06-30. ACET currently screens at market cap $75.7M.

Use this ACET page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ACET quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ACET SEC filings page. Lician reads the product cache first so this HTML stays unique to Adicet Bio Inc even when a live quote feed is slow.

Adicet Bio Inc latest statements (FY2025)

Latest cached year on this hub. Full ACET income, balance, and cash tables.

  • Revenue$5.8M
  • Net Income-$116.8M
  • Total Assets$192.4M
  • Total Debt$0
  • Free Cash Flow-$97.0M

ACET recent filings